Format

Send to

Choose Destination
See comment in PubMed Commons below
Lancet Infect Dis. 2006 Dec;6(12):805-12.

Rotavirus vaccines: considerations for successful implementation in Europe.

Author information

1
Centre for the Evaluation of Vaccination, University of Antwerp, Belgium. Pierre.VanDamme@ua.ac.be

Abstract

A group of European experts in infectious diseases and vaccinology has met on several occasions to assess the rationale for universal vaccination against rotavirus infection of infants in Europe. On the basis of the available data, we concluded that vaccination was the best approach to prevent severe rotavirus gastroenteritis, and that European countries should consider implementing rotavirus vaccination in their routine immunisation programmes. The main barrier to the implementation of rotavirus vaccination in Europe is a general lack of awareness of stakeholders, policymakers, health-care professionals, and parents about rotavirus disease and the advantages of vaccination. Further studies on the cost of the disease and the benefit of vaccination, together with raising awareness are necessary steps to ensure successful implementation of rotavirus vaccination in Europe.

PMID:
17123900
DOI:
10.1016/S1473-3099(06)70657-0
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center